Carpenter Technology (CRS): Director Granted 557 RSUs and 304 Options
Carpenter Technology Corp (CRS) reported an insider grant to director Kathleen Ligocki on 10/07/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Carpenter Technology Corp (CRS) reported an insider grant to director Kathleen Ligocki on 10/07/2025. She received 557 director stock units that convert 1-for-1 into common shares and are payable upon separation of service or a specified event, and was granted an option to buy 304 shares at a $256.27 exercise price exercisable beginning 10/07/2026 with a 10/07/2035 expiration. After these awards, the reporting person beneficially owned 25,754.12 shares (includes dividend equivalents). The grants were made under the Carpenter Technology Corporation stock-based compensation plan for non-employee directors and were reported on Form 4.
Positive
- 557 director stock units granted that convert 1-for-1 to common shares, increasing long-term alignment
- 304 stock option grant with clear $256.27 exercise price and defined exercisability and expiration dates
- 25,754.12 shares reported beneficially owned, including dividend equivalents, showing disclosed insider stake
Negative
- None.
Insights
Director grant aligns pay with long-term shareholder value.
These awards—557 director stock units and a 304-share option—are standard non-employee director compensation tied to continued service and future vesting or exercise conditions. The stock units convert 1-for-1 to common shares and include dividend equivalents, which increases the effective economic stake until payout.
The option has a $256.27 exercise price, a one-year wait before exercisability (10/07/2026), and a ten-year post-exercise window (10/07/2035), so alignment is delayed and contingent on tenure; monitor any future disclosures of vesting schedules or large additional grants within the next 12 months for governance impact.
Grants reflect routine director equity package, modest immediate dilution.
The 557 restricted stock units are payable later and the 304 option represents a small absolute share amount relative to total outstanding equity; dividend equivalents were included in the reported 25,754.12 beneficially owned shares. The option’s exercise price is explicit at $256.27, which sets the threshold for future executive value capture.
Because exercisability begins on 10/07/2026 and the option expires on 10/07/2035, the material near-term cash impact is limited; watch for vesting or exercise activity and aggregate director grants over the next 12 months for potential dilution effects.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Units | 557 | $0.00 | $0.00 |
| Grant/Award | Director Stock Option (Right to Buy) | 304 | $0.00 | $0.00 |
Footnotes (5)
- F1. Converts to common stock on a 1-for-1 basis
- F2. Payable upon the later of separation of service or a specified date or event.
- F3. The reporting person was granted restricted stock units under the Carpenter Technology Corporation Stock-Based Compensation Plan for Non-Employee Directors.
- F4. Includes dividend equivalents not previously reported.
- F5. The reporting person was granted an option to purchase stock under the Carpenter Technology Corporation Stock Based Compensation Plan for Non-Employee Directors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Carpenter Technology (CRS) report on Form 4?
When do the granted options for Kathleen Ligocki become exercisable (CRS)?
Under what plan were the equity awards granted (CRS)?
Do the director stock units pay out immediately (CRS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.